Mark Lance Shibuya

Array ( [id] => 3910126 [patent_doc_number] => 06001651 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Antisense modulation of LFA-3' [patent_app_type] => 1 [patent_app_number] => 9/045106 [patent_app_country] => US [patent_app_date] => 1998-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 29212 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001651.pdf [firstpage_image] =>[orig_patent_app_number] => 045106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409595 [patent_doc_number] => 06265388 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Antisense inhibition of angiogenin expression' [patent_app_type] => 1 [patent_app_number] => 9/045301 [patent_app_country] => US [patent_app_date] => 1998-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 25 [patent_no_of_words] => 15641 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265388.pdf [firstpage_image] =>[orig_patent_app_number] => 045301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3949685 [patent_doc_number] => 05955443 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Antisense modulation of PECAM-1' [patent_app_type] => 1 [patent_app_number] => 9/044506 [patent_app_country] => US [patent_app_date] => 1998-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 36126 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955443.pdf [firstpage_image] =>[orig_patent_app_number] => 044506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3909479 [patent_doc_number] => 06001611 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Modified nucleic acid amplification primers' [patent_app_type] => 1 [patent_app_number] => 9/039866 [patent_app_country] => US [patent_app_date] => 1998-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16193 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001611.pdf [firstpage_image] =>[orig_patent_app_number] => 039866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4113386 [patent_doc_number] => 06046050 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Human liver cell line' [patent_app_type] => 1 [patent_app_number] => 9/035396 [patent_app_country] => US [patent_app_date] => 1998-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 14 [patent_no_of_words] => 2108 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/046/06046050.pdf [firstpage_image] =>[orig_patent_app_number] => 035396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3996315 [patent_doc_number] => 05919917 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Photocleavable circular oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 9/011551 [patent_app_country] => US [patent_app_date] => 1998-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 8652 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919917.pdf [firstpage_image] =>[orig_patent_app_number] => 011551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4236038 [patent_doc_number] => 06090602 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Levo-monosaccharide in a nucleoside analog for use as an anti-retroviral agent' [patent_app_type] => 1 [patent_app_number] => 9/025530 [patent_app_country] => US [patent_app_date] => 1998-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 2184 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090602.pdf [firstpage_image] =>[orig_patent_app_number] => 025530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4182012 [patent_doc_number] => 06159731 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Daxx, a Fas-binding protein that activates JNK and apoptosis' [patent_app_type] => 1 [patent_app_number] => 9/022983 [patent_app_country] => US [patent_app_date] => 1998-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 27521 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159731.pdf [firstpage_image] =>[orig_patent_app_number] => 022983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4367815 [patent_doc_number] => 06287858 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'DeUBiquitinating enzymes that regulate cell growth' [patent_app_type] => 1 [patent_app_number] => 9/019095 [patent_app_country] => US [patent_app_date] => 1998-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 35 [patent_no_of_words] => 29445 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/287/06287858.pdf [firstpage_image] =>[orig_patent_app_number] => 019095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4101241 [patent_doc_number] => 06066625 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Optimized antisense oligonucleotides complementary to DNA methyltransferase sequences' [patent_app_type] => 1 [patent_app_number] => 9/018034 [patent_app_country] => US [patent_app_date] => 1998-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6374 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066625.pdf [firstpage_image] =>[orig_patent_app_number] => 018034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288638 [patent_doc_number] => 06183735 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Immortalized retinal pigmentary epithelial cell lines and their applications' [patent_app_type] => 1 [patent_app_number] => 8/973553 [patent_app_country] => US [patent_app_date] => 1998-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 48 [patent_no_of_words] => 7553 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/183/06183735.pdf [firstpage_image] =>[orig_patent_app_number] => 973553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4158952 [patent_doc_number] => 06103890 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Enzymatic nucleic acids that cleave C-fos' [patent_app_type] => 1 [patent_app_number] => 8/998099 [patent_app_country] => US [patent_app_date] => 1997-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 31871 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103890.pdf [firstpage_image] =>[orig_patent_app_number] => 998099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4106285 [patent_doc_number] => 06057126 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Mammalian EDG-5 receptor homologs' [patent_app_type] => 1 [patent_app_number] => 8/997803 [patent_app_country] => US [patent_app_date] => 1997-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16987 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057126.pdf [firstpage_image] =>[orig_patent_app_number] => 997803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4205295 [patent_doc_number] => 06027892 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Compositions and methods for reducing radiation and drug resistance in cells' [patent_app_type] => 1 [patent_app_number] => 8/991830 [patent_app_country] => US [patent_app_date] => 1997-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 6 [patent_no_of_words] => 9169 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/027/06027892.pdf [firstpage_image] =>[orig_patent_app_number] => 991830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406892 [patent_doc_number] => 06309826 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => '88kDa tumorigenic growth factor and antagonists' [patent_app_type] => 1 [patent_app_number] => 8/991862 [patent_app_country] => US [patent_app_date] => 1997-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 21 [patent_no_of_words] => 26096 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/309/06309826.pdf [firstpage_image] =>[orig_patent_app_number] => 991862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3932711 [patent_doc_number] => 05972613 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Methods of nucleic acid isolation' [patent_app_type] => 1 [patent_app_number] => 8/987329 [patent_app_country] => US [patent_app_date] => 1997-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5603 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972613.pdf [firstpage_image] =>[orig_patent_app_number] => 987329 [rel_patent_id] =>[rel_patent_doc_number] =>)